Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem penetration into epithelial lining fluid during continuous infusion in mechanically ventilated ICU patients
2012-000443-27Phase 3Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of meropenem in pneumonia, cutaneous infection and bacterial disease, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Meropenem concentration in plasma and epithelial lining fluid. Started Mar 2012; status: terminated.
02
Drugs
meropenem
03
Conditions
pneumoniacutaneous infectionbacterial disease
Beyond the preview
Go deeper on 2012-000443-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000443-27.